Company / Debt per Share
Zenas BioPharma, Inc. Debt per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.88
FY2025
5-year range
$1.88 / $1.88
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#44 of 82
Health Care
What the data says
At $1.88, Zenas BioPharma, Inc.'s debt per share ranks #39 of 82 in the Health Care sector.
Based on SEC 10-K filings.
1.88 in FY2025.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#39 of 82 in Health CareTop 46% of 82This company $1.88 Sector average $151.59
▼
-98.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.88 | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026